Search

everythinglearnresearchcommunity

for

Search:↓

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

DM and AA may share a common cause.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Immune changes and specific genes contribute to male hair loss.

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

A man with skin and hair symptoms improved partially with specific treatment.

Combination therapies might work better for some vitiligo patients, but results vary.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Fixing DNA errors is crucial to prevent skin cancer.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.